First derivative spectrophometric determination of mosapride citrate in bulk drugs and pharmaceutical preparations

Indian Drugs

Volumn 42, Issue 7, 2005, Pages 437-442

  Nageswara, R R ^a   Nagaraju, D ^a   Narasaraju, A ^a  

^a India Institute of Chemical Technology   (India)

Author keywords

Assay; Bulk drugs pharmaceutical dosage forms; First derivative spectrophotometry; Mosapride citrate

Indexed keywords

EID: 31344481557     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Craig A. D., Clerke D. E. Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor, J.Pharm.Exp.Ther., 1990, 252, 1378-1386.
2. Fernadez A. G., Roberts D. J. Cinitapride hydrogen tartarate, Drugs of Future 1991,16 (10), 885-892.
3. 4 receptor agonist, Eur. J. Pharmacol., 1990,183 (suppl. 6), 2181-2181.
4. Yoshida N., Ito T., Karasawa T. and Ito Z. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs J. Pharm. Exp. Ther., 1991, 257, 781-787.
5. Goh K. L., Chang C. S., Fock K. M., Ke M., Park H. J. and Lam S. K. Gastro-oesophageal reflux disease in Asia, J. Gastroenterol. Hepatol., 2000, 15, 230-238.
6. Reynold J. C. Prokinetic agents a key in the future of gastroenterology, Gastroenterol.Clin. North Am., 1989, 18, 437-457.
7. KrishnaiahY. S., Murthy T. K., Sankar D. G. and Satyanarayana V. The determination of mosapride citrate in bulkdrug samples and pharmaceuticals dosage forms using HPLC, Anal. Sci., 2002,18, 1269-1271.
8. Krishnaiah Y. S., Murthy T. K., Sankar D. G. and Satyanarayana V. A validated RP-HPLC method for the determination of mosapride citrate in bulkdrug samples and pharmaceuticals formulations, Pharmazie 2002, 57, 814-816. (Pubitemid 36014613)
9. Sakashita M., Mizuki Y., Hashizume T., Yamaguchi T., Miyazaki H. and Sekine Y. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in rats, Arzeim-Forsch./Drugs Res., 1993, 43(II), 859-863. (Pubitemid 23254934)
10. Sakashita M., Mizuki Y., Hashizume T., Yamaguchi T., Miyazaki H. and Sekine Y. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in dogs and monkeys, Arzeim-Forsch./Drugs Res., 1993, 43(II), 864-866. (Pubitemid 23254935)
11. Sakashita M., Yamaguchi T., Miyazaki H., Sekine Y., Nomiyama T., Tanaka S. and Harasawa S. Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects Arzeim-Forsch./Drugs Res., 1993, 43(II), 867-872.
12. Yokoyama I., Mizuki Y., Yamaguchi T. and Fujii T. Simultaneous enantiomeric determination of gastroprokinetic agent mosapride citrate and its metabolite in plasma using α1-acid glycoprotein, J. Pharm. Biomed. Anal., 1997, 15, 1527-1535. (Pubitemid 27268331)
13. Karlsson A., Aspegren A. The use of mobile phase pH and column temperature to reverse the retention order of enantiomers on Chiral-AGP, Chromatographia 1998, 47 (3/4), 189-196. (Pubitemid 28082022)
14. Ravindra kumar Y., Moses Babu J., Seshidhar B., Reddy S. S., Reddy G. S. and Vyas K. Application of LC-MS/MS for the identification of polar impurity in mosapride citrate, a gastroprokinetic drug, J. Pharm. Biomed. Anal., 2003, 32, 361-368.
15. Kuchekar B. S., Usha Adagale, Nagar M. and Bhise S. B. Spectrophotometric method for estimation of mosapride citrate in tablets, Ind. J. Pharma. Sci., 2003, 65(1), 85-86.